Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Congenital analbuminemia (CAA) is characterized by the absence or dramatic reduction of circulating human serum albumin (HSA).
Features include always present findings: Hypercholesterolemia, Increased LDL cholesterol concentration, Hypoalbuminemia, and Fatigue and others; and common findings: Recurrent lower respiratory tract infections and Lipodystrophy. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 2 | Increased LDL cholesterol concentration, Elevated circulating transferrin concentration |
ALB encodes albumin (609 aa). Binds water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs (Probable). Its main function is the regulation of the colloidal osmotic pressure of blood (Probable). Highest expression in Liver (25,201 TPM) and Pancreas (323.3 TPM).
Congenital analbuminemia is caused by mutations in the ALB gene on chromosome 4.
ALB is classified as a druggable target (Druggable Genome and Transporter categories) with score 2.4.
Genetic testing for ALB is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 7 always present features, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for congenital analbuminemia.
3 publications have been identified in PubMed for congenital analbuminemia. Research spans Basic Science / Preclinical (67%) and Review / Meta-Analysis (33%).
Zhang Y (2025). [PMID: 40654176](https://pubmed.ncbi.nlm.nih.gov/40654176/). *Adipocyte*. [Basic Science / Preclinical]
Abdollahi A (2024). [PMID: 39123208](https://pubmed.ncbi.nlm.nih.gov/39123208/). *Lipids Health Dis*. [Basic Science / Preclinical]
Avgoustou E (2024). [PMID: 39185032](https://pubmed.ncbi.nlm.nih.gov/39185032/). *Metabol Open*. [Review / Meta-Analysis]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 11:23 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about congenital analbuminemia
Brain and nerves |
2 |
Global developmental delay, Fatigue |
Lungs and breathing | 1 | Recurrent lower respiratory tract infections |
Blood and immune system | 1 | Recurrent lower respiratory tract infections |
Digestive system | 1 | Increased LDL cholesterol concentration |
Bones and joints | 1 | Weak and brittle bones (osteoporosis) |
Age of onset: before birth.